Jan 13, 2023 / Presentations Medicare Part D: Status report Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing, Quality
Sep 29, 2022 / Transcripts September 29-30, 2022 meeting transcripts Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Quality
Sep 29, 2022 / Presentations Analysis of Part D data on drug rebates and discounts Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing
Jun 15, 2022 / Reports June 2022 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jun 15, 2022 / Chapters Executive summary (June 2022 report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Jun 15, 2022 / Chapters Chapter 7: Segmentation in the stand-alone Part D plan market (June 2022 report) Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests
Jun 15, 2022 / Chapters Appendix A: Commissioners’ voting on recommendations (June 2022 report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues
Jun 15, 2022 / Press Releases MedPAC releases June 2022 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues
Apr 07, 2022 / Presentations Segmentation in the stand-alone Part D prescription drug plan market Research Areas: Drugs, Devices, and Tests
Apr 07, 2022 / Presentations Initial findings from MedPAC’s analysis of Part D data on drug rebates and discounts Research Areas: Drugs, Devices, and Tests